Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038358 (
gastric ulcer
)
5,179
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CCN1
is a matricellular protein that activates many genes related to wound healing and tissue remodeling in fibroblasts, but its effect on epithelial cells remains unclear. This study examined the role of
CCN1
in epithelial wound healing using rat gastric epithelial cells and rat
stomach ulcer
as in vitro and in vivo models, respectively. We found that
CCN1
expression is highly upregulated in the epithelial cells adjacent to a wound and remains high until the wound is healed. Upregulation of
CCN1
activates a transient epithelial-mesenchymal transition in the epithelial cells at the migrating front and drives wound closure. Once the wound is healed, these epithelial cells and their progeny can resume their original epithelial phenotype. We also found that
CCN1
-induced E-cadherin loss is not due to transcriptional regulation but rather protein degradation due to the collapse of adherens junctions, which is contributed by beta-catenin translocation.
CCN1
-activated integrin-linked kinase mediates this process. Finally, our in vivo study showed that locally neutralizing
CCN1
drastically impairs wound closure, whereas local injection of recombinant
CCN1
protein induces expression of vimentin and smooth muscle alpha-actin in normal gastric mucosal epithelial cells and accelerates re-epithelialization during ulcer healing. In conclusion, our study indicates that
CCN1
can induce reversible epithelial-mesenchymal transition, and this feature may have great value for clinical wound healing.
...
PMID:CCN1 induces a reversible epithelial-mesenchymal transition in gastric epithelial cells. 2045 73